Search

The world’s top competitors in the 2026 Olympics, which continue through Feb. 22, may offer a valuable lesson to those seeking to improve their workouts or just to get more active. While these elite athletes are performing at a peak level on a global stage, it’s the work they put in behind the scenes during training and conditioning that really sets them up for success.

Lorena Saelices Gomez, Ph.D., Assistant Professor of Biophysics and in the Center for Alzheimer’s and Neurodegenerative Diseases at UT Southwestern, has been awarded $1.5 million from the National Institutes of Health (NIH) to determine the structure of amyloids, key proteins that have been tied to diseases including Alzheimer’s and ATTR amyloidosis.

UT Southwestern researchers have identified a new mechanism by which stress causes cells to stop dividing.

A new study in mice led by neuroscientists at UT Southwestern’s Peter O’Donnell Jr. Brain Institute shows that it’s not just calories that count, but also when they’re consumed.

A UT Southwestern research team has received the National Institutes of Health’s prestigious Transformative Research Award to further their study of zebra finches to investigate the genetic basis of vocal imitation abilities.

A team of researchers at UT Southwestern Medical Center’s Touchstone Diabetes Center have successfully used CRISPR gene editing to turn fat cells normally used for storage into energy-burning cells.

An international panel of experts from four renowned diabetes research centers, including UT Southwestern Medical Center, has reviewed current literature and is recommending a pivotal change in treatment of Type 2 diabetes to focus on obesity first and glucose control second.

UT Southwestern Medical Center has been selected as a Rare Disease Center of Excellence – charter members of an elite network of 31 centers nationally to expand access, and advance care and research for rare disease patients in the United States.

Forbes and Statista have selected UT Southwestern among the top 40 Best Employers for Women 2021.

Moderately ill patients hospitalized with COVID-19 have better chances of survival if treated with therapeutic-dose anticoagulation, according to an international study involving 121 sites, including UT Southwestern Medical Center.